VS
First Trust AlphaDEX U.S. Health Care Sector Index ETF (FHH) and First Trust NYSE Arca Biotechnology ETF (FBT) offer distinct profiles for Canadian ETF investors. A direct comparison shows that FHH focuses its top 3 sector exposures on Healthcare, while FBT leans towards Healthcare. When evaluating costs, FHH features a management fee (MER) of 0.7%, compared to 0.15% for FBT. Performance-wise, FHH has returned 22.07% year-to-date with -$2 M in net flows, whereas FBT is at 34.59% with +$5 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
FHH
FBT
| AuM | $5.11 M | $8.17 M |
| Management Fees | 0.70% | 0.15% |
| Exp. ratio | 0.76% | 0.71% |
| Tracking Difference | -1.08% | - |
Historical performance and flows
As of October 20, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | FHH | +3.56% | +10.91% | +22.07% | +19.99% | +48.69% |
FBT | +0.90% | +10.68% | +34.59% | +43.54% | +101.50% | |
| Flows | FHH | +$0 M | +$0 M | -$2 M | -$4 M | -$8 M |
FBT | +$0 M | +$1 M | +$5 M | +$4 M | +$4 M |
FHH vs FBT exposure
Countries
FHH
USA
93.13%
FBT
USA
82.68%
Other
17.32%
Sectors
FHH
Healthcare
98.23%
FBT
Healthcare
99.86%
As of October 20, 2026
Top 10 Holdings
FHH
Regeneron Pharmaceuticals, Inc.
2.86%
Pfizer Inc.
2.56%
Solventum Corp.
2.55%
Natera, Inc.
2.55%
Zimmer Biomet Holdings, Inc.
2.49%
Universal Health Services, Inc.
2.48%
Boston Scientific Corp.
2.43%
Guardant Health, Inc.
2.37%
Tenet Healthcare Corp.
2.29%
Halozyme Therapeutics, Inc.
2.22%
FBT
Halozyme Therapeutics, Inc.
4.38%
Regeneron Pharmaceuticals, Inc.
3.84%
NeoGenomics, Inc.
3.83%
Corcept Therapeutics, Inc.
3.82%
Amgen, Inc.
3.74%
BeOne Medicines Ltd.
3.72%
Natera, Inc.
3.68%
Repligen Corp.
3.65%
argenx SE
3.63%
Gilead Sciences, Inc.
3.58%
Diversification
FHH
Total weight of top 10 holdings out of 72 total
24.80%
FBT
Total weight of top 10 holdings out of 30 total
37.87%
Characteristics
Compare
FHH
FBT
| Provider | First Trust | First Trust |
| Management | Passively managed | Passively managed |
| Benchmark | StrataQuant Health Care CAD Total Return Index - CAD | NYSE Arca Biotechnology Total Return Index - USD |
| Replication Method | Direct (Physical) | Other |
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 0.47% | 0.00% |
| Meets ESG criteria | No | No |
| Inception Date | October 30, 2014 | October 30, 2014 |
Frequently asked questions about FHH and FBT
Which ETF has performed better year to date: FHH or FBT?
As of October 20, 2026, FHH has returned 22.07% year to date, while FBT has returned 34.59%. FBT is ahead on YTD performance.
Which ETF is larger by assets under management: FHH or FBT?
As of October 20, 2026, FHH manages $5.11 M in assets, while FBT manages $8.17 M. FBT is the larger fund by AUM.
How are FHH and FBT managed?
FHH is passively managed by First Trust. It tracks the StrataQuant Health Care CAD Total Return Index - CAD benchmark. FBT is passively managed by First Trust. It tracks the NYSE Arca Biotechnology Total Return Index - USD benchmark.
What sectors do FHH and FBT emphasize?
FHH is most exposed to Healthcare. FBT is most exposed to Healthcare.
Which ETF is attracting more investor flows: FHH or FBT?
Year to date, FHH has seen -$2.10 M in net flows, compared with +$4.83 M for FBT. FBT has attracted more net investor money so far.
How do the fees of FHH and FBT compare?
FHH has an expense ratio of 0.76%, while FBT has an expense ratio of 0.71%.
What are the top holdings of FHH and FBT?
FHH's largest holdings include Regeneron Pharmaceuticals, Inc., Pfizer Inc., and Solventum Corp.. FBT's top holdings include Halozyme Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., and NeoGenomics, Inc..
Which ETF is more diversified: FHH or FBT?
FHH holds 72 securities, while FBT holds 30. On holdings count, FHH is the more diversified portfolio.
Recent articles about FHH and FBT
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.